Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Claude Cormier who wrote (3355)	2/9/2000 6:49:00 AM
From: Mark Bartlett	Respond to of 14101

Claude, <<Maybe the same bunch who carried Biomira from $6 to $21 in January. BRA doesn't seem to have a lot more going than DMX.Maybe the same bunch who carried Biomira from $6 to $21 in January. BRA doesn't seem to have a lot more going than DMX.>> Certainly there will be a lot of interest in their breast cancer and lung cancer vaccines -- they have a lot of market appeal. As far as absolute revenue generating potential, IMO BRA's is not nearly as great. MB

To: Claude Cormier who wrote (3355)	2/9/2000 9:34:00 AM
From: frozenpizzaman	Read Replies (1) \| Respond to of 14101

Thanks Mark and Wolf for the advice and help. I put it into DMX this morning that gives me a only 2400 shares wish it was more. But over the next couple weeks my wife and mine IRA Stocks can be changed so i am putting it all in DMX. I am from the US what is the exchange rate and how do i figure it out. I think my price per share will still be about $5.50 Canadian so that still isnt bad. Agian Thanks for the help and am happy that i was tipped to this stock because it has great potential. Plus all the people on this thread are friendly and helpful.